NASDAQ:KARD

Kardigan (KARD) Stock Price, News & Analysis

$11.49 -1.03 (-8.23%)
As of 11/20/2026 03:59 PM Eastern

About Kardigan Stock (NASDAQ:KARD)

Advanced

Key Stats

Today's Range
$11.49
▼
$12.77
50-Day Range
$11.49
▼
$19.05
52-Week Range
$11.49
▼
$27.00
Volume
459,244 shs
Average Volume
497,709 shs
Market Capitalization
$1.08 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$41.00
Consensus Rating
Moderate Buy

Company Overview

Kardigan is a biopharmaceutical company focused on developing medicines for cardiovascular diseases. Its work centers on advancing therapeutic candidates intended to address heart and vascular conditions.

The company’s activities include research and development of a pipeline of cardiovascular drug candidates. Kardigan was launched as a biotechnology company in 2024; detailed information about its commercial products and geographic operations is limited.

AI Generated. May Contain Errors.

Kardigan Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

KARD MarketRank™: 
2.340157038695 of 5 stars

Kardigan scored higher than 47% of companies evaluated by MarketBeat, and ranked 523rd out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Kardigan has received a consensus rating of Moderate Buy. The company's average rating score is 2.90, and is based on 2 strong buy ratings, 6 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Kardigan has a consensus price target of $41.00, representing about 256.8% upside from its current price of $11.49.

  • Amount of Analyst Coverage

    Kardigan has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Kardigan's stock forecast and price target.
  • Earnings Growth

    Earnings for Kardigan are expected to decrease in the coming year, from ($3.39) to ($3.85) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Kardigan is -3.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Kardigan is -3.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Kardigan has a P/B Ratio of 1.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    6.09% of the float of Kardigan has been sold short.
  • Short Interest Ratio / Days to Cover

    Kardigan has a short interest ratio ("days to cover") of 11.19, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Kardigan has recently increased by 7.38%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Kardigan does not currently pay a dividend.

  • Dividend Growth

    Kardigan does not have a long track record of dividend growth.

  • News Sentiment

    Kardigan has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for Kardigan this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for KARD on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Kardigan insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Kardigan has minimal institutional ownership at this time.

  • Read more about Kardigan's insider trading history.
Receive KARD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kardigan and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KARD Stock News Headlines

Kardigan (NASDAQ:KARD) Stock Rating Raised to "Hold" at Wall Street Zen
HC Wainwright Analysts Raise Earnings Estimates for Kardigan
A $247 tool for $7
Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.tc pixel
Kardigan Q3 Net Loss Falls
Kardigan: Q3 earnings snapshot
Transcript : Kardigan, Inc. - Special Call
See More Headlines

KARD Stock Analysis - Frequently Asked Questions

Kardigan's stock was trading at $22.00 on June 18, 2026. Since then, KARD stock has decreased by 47.8% and is now trading at $11.49.

Kardigan, Inc. (NASDAQ:KARD) issued its quarterly earnings results on Thursday, November, 12th. The company reported ($0.64) EPS for the quarter, topping the consensus estimate of ($0.80) by $0.16.

Kardigan (KARD) raised $400 million in an initial public offering (IPO) on Thursday, June 18th 2026. The company issued 25,000,000 shares at $16.00 per share.

Kardigan's lock-up period expires on Tuesday, December 15th. Kardigan had issued 25,000,000 shares in its initial public offering on June 18th. The total size of the offering was $400,000,000 based on an initial share price of $16.00. After the end of the company's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Top institutional investors of Kardigan include Goldman Sachs Group Inc. (0.58%), State Street Corp (0.49%), Integral Health Asset Management LLC (0.24%) and Jump Financial LLC (0.02%). Insiders that own company stock include Paul L Berns and Arch Venture Partners Xiii, Ll.
View institutional ownership trends
.

Shares of KARD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/12/2026
Today
11/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:KARD
CIK
2123613
Fax
N/A
Employees
241
Year Founded
N/A

Price Target and Rating

High Price Target
$50.00
Low Price Target
$25.00
Potential Upside/Downside
+256.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$191.94 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-152.99%
Return on Assets
-46.19%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.62
Quick Ratio
10.62

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.12 per share
Price / Book
1.88

Miscellaneous

Outstanding Shares
93,600,000
Free Float
N/A
Market Cap
$1.08 billion
Optionable
Optionable
Beta
N/A
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:KARD) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners